Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Moricizine Hydrochloride (EN 313) is an orally active class I antiarrhythmic agent that reduces the maximum rate of phase 0 depolarisation; increases the repolarisation rate of phases 2 and 3, reduces the duration of action potentials and reduces the effective non-response period.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | Moricizine Hydrochloride (EN 313) is an orally active class I antiarrhythmic agent that reduces the maximum rate of phase 0 depolarisation; increases the repolarisation rate of phases 2 and 3, reduces the duration of action potentials and reduces the effective non-response period. |
Molecular Weight | 463.98 |
Formula | C22H26ClN3O4S |
CAS No. | 29560-58-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Moricizine Hydrochloride 29560-58-5 inhibitor inhibit